News Image

GH Research Announces Global Pivotal Program Plans and Further Development Updates

Provided By GlobeNewswire

Last update: Jul 23, 2025

DUBLIN, July 23, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today provided updates on its business and key upcoming milestones.

Read more at globenewswire.com

GH RESEARCH PLC

NASDAQ:GHRS (10/14/2025, 4:06:19 PM)

After market: 13.32 0 (0%)

13.32

+0.36 (+2.78%)



Find more stocks in the Stock Screener

Follow ChartMill for more